Due to the geographical proximity and resource endowment of the Sichuan and Chongqing regions, the economic development forms tend to be the same. As a key high-tech industry in the country, Sichuan and Chongqing have also introduced various policies to promote the healthy development of the industry in recent years, such as the "Measures for the Supervision of Medical Device Production in Sichuan and Chongqing (Trial)".
Pharmaceutical intelligence medical device data pairsChongqing Municipality and its districts, Sichuan Province and its citiesThe relevant policies of medical devices are summarized, and only some of the policies are listed due to space limitations, and the original link to the policy is attached to the text. The following is a brief overview of the policy:
Table 1 List of subsidy policies for some medical devices in Sichuan and Chongqing
Data**: Summary of data from official websites and medical devices in various regions.
01 Sichuan Province
Major scientific and technological projects, import substitution or domestic initiatives for medical and health equipmentIndustrialization projects such as high-end medical and health equipment and key complete sets of equipmentAccording to the proportion of 10% of the investment amount, the maximum amount shall not be exceeded50 million yuan subsidy。Yes to getClass III Medical Device Registration Certificate(National Innovative Medical Devices) and industrialization projects, a reward of 5 million yuan will be given. For projects that have obtained the registration certificate of Class II and Class III medical devices (excluding diagnostic reagents, low-value consumables and national innovative medical devices) and industrialized, or projects that have been registered and listed in European and American countries for Class III medical devices in China, the maximum shall not be exceeded2 million yuanReward.
In-depth implementationMedical device registrant systemFor enterprises entrusted with the production of medical devices registered for the first time, the proportion of 2% of the actual annual execution amount of the entrusted production contract shall not be exceeded2 million yuanSubsidy.
People of Sichuan Province**.
Policy Links:
Sichuan Province - Chengdu City
Support qualified medical institutions to apply for the qualification of drug and medical device clinical trial institutions (filing), and for those who undertake the research and development of new drugs and medical devices and complete clinical trials, according to the project amountThe total amount of subsidy for each medical institution shall not exceed the total amount of subsidy each year2 million yuan。Clinical trial beds are not included in the total number of beds in medical institutions, and evaluation indicators such as bed efficiency, turnover rate, and utilization rate are not stipulated.
Chengdu Municipal Health Commission.
Policy Links:
Sichuan Province - Bazhong City
In-depth implementation of the medical device registrant system, for enterprises entrusted with the production of medical devices registered for the first time, according to the proportion of 2% of the annual actual execution amount of the entrusted production contract, the maximum shall not be exceeded2 million yuanSubsidy. For enterprises that carry out financial leasing services for key medical and health equipment and have an actual execution amount of more than 20 million yuan in the contract year, the maximum shall not exceed 2% of the actual execution amount1,000,000 yuanSubsidy.
Enterprises that have obtained Class II and Class III medical device registration certificates (excluding Class II diagnostic reagents and equipment parts) will be given respectively500,000 yuan1,000,000 yuanAwards, the maximum annual reward for a single enterprise is not exceeded5 million yuan
For those who have landed production and settlement in the city and have a continuous production time of not less than 3 years, the maximum number of single varieties of the three types of medical devices shall not be exceeded500,000 yuanReward.
For drugs (including APIs) and medical devices that have been newly approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA), the World Health Organization (WHO) and other institutions and have obtained overseas marketing qualifications, the maximum amount of each product shall not be exceeded1,000,000 yuanRewards, up to a single enterprise5 million yuanReward.
People of Bazhong City**.
Policy Links:
Sichuan Province - Dazhou City
A one-time subsidy will be given to high-tech enterprises identified for the first time300,000 yuanA one-time subsidy will be given to the re-identified high-tech enterprises100,000 yuanIf the overall new relocation and registration tax payment is in Dazhou City and the validity period is more than 2 years, the subsidy will be given according to the first recognition standard. For high-tech enterprises with annual R&D investment of more than 2 million yuan approved by the tax department, 3% of R&D investment will be given500,000 yuanIn the tank. The subsidy funds shall be borne by the beneficiary local finance, and the municipal finance shall provide financial support according to 30% of the actual subsidy amount of the beneficiary local finance.
Dazhou Science and Technology Bureau.
Policy Links:
Guang'an City, Sichuan Province
For enterprises with annual R&D investment of more than 500,000 yuan, according to R&D investmentAbove, the highest to give2 million yuanIn the tank.
People of Sichuan Province**.
Policy Links:
Mianyang City, Sichuan Province
Yes to getClass II and Class III medical device registration certificates(excluding diagnostic reagents and low-value consumables) and generated for sales in local industrialization, the maximum shall be given according to 10% of the approved investment800,000 yuanone-time rewards.
RightIt is registered and listed in European and American countries(At the same time, it has obtained the registration certificate of domestic Class III medical devices).And in the city of industrialization and the realization of the corresponding national export, according to the approved investment of 10% of the maximum to give the highest1,000,000 yuanone-time rewards.
Mianyang Municipal Bureau of Economy and Information Technology.
Policy Links:
07 Chongqing
For approved inclusionNational Special Review Procedures for Innovative Medical Devicesof medical device products, not more than 20% of R&D investment is given, the highest5 million yuanFinancial support.
10 million yuan will be awarded for each innovative drug, 5 million yuan will be awarded for each improved new drug and biosimilar, and 1 million yuan will be awarded for each classic prescription product of traditional Chinese medicineThe third class of medical devices will be rewarded with 1 million yuan each
Drugs that have been registered with international agencies such as FDA (Food and Drug Administration), EMA (European Medicines Agency), CE (European Community), PMDA (Japan Pharmaceuticals and Medical Devices Agency) or WHO (World Health Organization) and are sold in relevant foreign marketsHigh-end medical devices, after selection, given the highest1,000,000 yuanOne-time reward.
For production enterprises undertaking CDMO CMO business of non-affiliated enterprises and institutions, if the annual entrusted service income exceeds 10 million yuan, the entrusted enterprise shall be given a maximum of 3% of the annual service income amount5 million yuanone-time rewards.
Chongqing Municipal People**.
Policy Links:
Chongqing - Jiulongpo District
For those who have independent intellectual property rights and have obtained the first registration certificateClass II and III medical devicesmachineryNew product development projects, respectively, give100,000 yuan200,000 yuanone-time grant.
Chongqing Project Application Service Center.
Policy Links:
Chongqing Municipal Economic Development Zone
After the medical device registrant obtains the registration approval and production license of the medical device product of the class, class and the national medical device priority approval channel, it will be given respectivelyR&D awards for medical device registrants
RightAnnual sales revenue of the medical device registrantIf it reaches 50 million yuan, 100 million yuan, and 300 million yuan for the first time, it will be rewarded respectively, and the annual reward for a single enterprise shall not exceed its direct economic contribution in the current year.
For products that have been registered by FDA (Food and Drug Administration), EMA (European Medicines Agency), CE (European Harmonization), PMDA (Japan Agency for Drugs and Medical Devices), WHO (World Health Organization) and other international institutions, and sold in relevant foreign marketsThe enterprise will be rewarded
Chongqing Economic and Technological Development Zone.
Policy Links: